Cross-Resistance between Fluconazole and Ravuconazole and the Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Ravuconazole among 12,796 Clinical Isolates of Candida spp.
Cross-resistance within a class of antimicrobial agents is a problem that is often encountered with antibacterial agents, and it is also an issue with antifungal agents. A current example is ravuconazole, a new triazole antifungal with an expanded spectrum and potency against Candida spp., Aspergill...
Guardat en:
| Publicat a: | J Clin Microbiol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
2004
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC446250/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15243072/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.42.7.3137-3141.2004 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|